Technology has changed the healthcare industry in many areas - including marketing and customer management. As we move forward, it is very likely that certain trends will expand and grow, impacting pharma and healthcare marketing and improving both sales and patient outcomes. Here are five trends we believe pharmaceutical companies should watch for and consider embracing in 2018 and beyond.
Whether you’re knowledgeable on Clinical Trials and the process that goes into it or not, it is correctly assumed that the work is far from light. There are four phases for each study conducted that tells the plot of the story, but doesn’t dive into the supporting elements within.
Every industry is changing at a more and more rapid pace. Products and services are becoming increasingly commercialized. Technology is playing a progressively bigger role in research and development, marketing and advertising, and sales and distribution. The pharmaceutical sector is one that has felt this transformation in research and development over the past few years and will start to feel it in the other divisions over the next decade. Here are just a few of the trends that will shape the pharmaceutical industry over the next ten years:
Digital is transforming the way the "sales" is done, and healthcare is no exception. According to GreatCall, around 80% of healthcare providers are using smartphones and medical apps daily in their practice. More and more of the top pharma companies now have a chief digital officer or chief technology officer while others are creating digital management roles at the senior level. When you think about digital-forward initiatives performance across industries, do you feel that pharma is behind the curve? Are you unsure how to leverage technology to enhance the sales process? Are you worried about how the digital age will impact your position? If you answered "yes," you are not alone.
The emergence of big data and advancements in technology and data science approaches has dramatically transformed industries like retail, finance, and travel. The Life Sciences industry is no exception. Companies in the Life Sciences industry have a high-volume of unorganized data sets they are not aware of that contains hidden actionable insights. Life sciences industry is the early adopters of new technologies but still, a huge number of enterprises have not been able to decode the insights because of lack of expertise in pharma data analytics and inefficient pharma master data management.
Swapan Kumar Manna | July 19, 2017
Anupam Nandwana | January 5, 2018
Anupam Nandwana | February 8, 2017
Swapan Kumar Manna | December 19, 2017
Avirup Basu | June 7, 2018